Bacteriophage-Based Therapy in Cystic Fibrosis-Associated Pseudomonas Aeruginosa Infections: Rationale and Current Status

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s53123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Initial Pseudomonas Aeruginosa Treatment Failure Is Associated With Exacerbations in Cystic Fibrosis

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2011English

Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Monotherapy Versus Combination Therapy for the Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients

Journal of Antibiotics Research
2018English

Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1994English

The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas Aeruginosa Infection in Non-Cystic Fibrosis Bronchiectasis

Journal of Aerosol Medicine and Pulmonary Drug Delivery
PulmonaryRespiratory MedicinePharmacologyPharmaceutical Science
2018English

Change in Pseudomonas Aeruginosa Prevalence in Cystic Fibrosis Adults Over Time

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2016English

Phenotypic Heterogeneity of Pseudomonas Aeruginosa Populations in a Cystic Fibrosis Patient

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy